Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Richter

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Immunology|August 26, 2009
CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expressionG H S Richter, A Mollweide, K Hanewinkel, et al.
Biology of the Cell|November 8, 2011
Defining the role of TRIP6 in cell physiology and cancerSemjon Willier, Elke Butt, Günther H S Richter, et al.
Klinische Padiatrie|November 6, 2009
Only therapeutic ICOS:ICOSL blockade alleviates acute graft versus host diseaseA Mollweide, M S Staege, C Hoeschen, et al.
Cancers|November 27, 2025
The Puzzle of Genetic Stability and Chromosomal Copy Number Alterations for the Therapy of Ewing SarcomaGünther H S Richter, Andreas Ranft, Maximilian Kerkhoff, et al.
Genes, Chromosomes & Cancer|April 12, 2014
Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entitiesKatja Specht, Yun-Shao Sung, Lei Zhang, et al.
British Journal of Cancer|March 17, 2011
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cellsU Thiel, S Pirson, C Müller-Spahn, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2009
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2Stefan Burdach, Stephanie Plehm, Rebekka Unland, et al.
Oncoimmunology|March 28, 2017
Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma <i>in vitro</i> and <i>in vivo</i>Andreas Kirschner, Melanie Thiede, Thomas G P Grünewald, et al.
The American Journal of Surgical Pathology|January 12, 2016
Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell SarcomasKatja Specht, Lei Zhang, Yun-Shao Sung, et al.
Oncotarget|December 2, 2015
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcomaTim Hensel, Chiara Giorgi, Oxana Schmidt, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Immunology|August 26, 2009
CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expressionG H S Richter, A Mollweide, K Hanewinkel, et al.
Biology of the Cell|November 8, 2011
Defining the role of TRIP6 in cell physiology and cancerSemjon Willier, Elke Butt, Günther H S Richter, et al.
Klinische Padiatrie|November 6, 2009
Only therapeutic ICOS:ICOSL blockade alleviates acute graft versus host diseaseA Mollweide, M S Staege, C Hoeschen, et al.
Cancers|November 27, 2025
The Puzzle of Genetic Stability and Chromosomal Copy Number Alterations for the Therapy of Ewing SarcomaGünther H S Richter, Andreas Ranft, Maximilian Kerkhoff, et al.
Genes, Chromosomes & Cancer|April 12, 2014
Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entitiesKatja Specht, Yun-Shao Sung, Lei Zhang, et al.
British Journal of Cancer|March 17, 2011
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cellsU Thiel, S Pirson, C Müller-Spahn, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2009
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2Stefan Burdach, Stephanie Plehm, Rebekka Unland, et al.
Oncoimmunology|March 28, 2017
Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma <i>in vitro</i> and <i>in vivo</i>Andreas Kirschner, Melanie Thiede, Thomas G P Grünewald, et al.
The American Journal of Surgical Pathology|January 12, 2016
Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell SarcomasKatja Specht, Lei Zhang, Yun-Shao Sung, et al.
Oncotarget|December 2, 2015
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcomaTim Hensel, Chiara Giorgi, Oxana Schmidt, et al.
Pageof 4